Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu von De Grève, J, Teugels, E, Geers, C, Decoster, L, Galdermans, D, De Mey, J, Everaert, H, Umelo, I, Veld, P. In’t, Schallier, D

Volltext

Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016) von Goossens, M, De Brabander, I, De Grève, J, Van Ongeval, C, Martens, P, Van Limbergen, E, Kellen, E

Volltext

Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients von De Brakeleer, S., De Grève, J., Desmedt, C., Joris, S., Sotiriou, C., Piccart, M., Pauwels, I., Teugels, E.

Volltext

Phosphorylated STAT3 physically interacts with NPM and transcriptionally enhances its expression in cancer von Ren, Z, Aerts, J L, Pen, J J, Heirman, C, Breckpot, K, De Grève, J

Volltext

Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer von Decoster, L., Kenis, C., Schallier, D., Vansteenkiste, J., Nackaerts, K., Vanacker, L., Vandewalle, N., Flamaing, J., Lobelle, J. P., Milisen, K., De Grève, J., Wildiers, H.

Volltext

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study von Joris, S., Denys, H., Collignon, J., Rasschaert, M., T’Kint de Roodenbeke, D., Duhoux, F.P., Canon, J.-L., Tejpar, S., Mebis, J., Decoster, L., Aftimos, P., De Grève, J.

Volltext

Integrating communication as a core skill in the global curriculum for medical oncology von Horlait, M., Leys, M., De Grève, J., Van Belle, S.

Volltext

The delay-time distribution of Type Ia supernovae: a comparison between theory and observation von Mennekens, N., Vanbeveren, D., De Greve, J. P., De Donder, E.

Volltext

Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium von Goossens, M, Van Hal, G, Van der Burg, M, Kellen, E, Van Herck, K, De Grève, J, Martens, P, Van Limbergen, E

Volltext

The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers von Van Laethem, J. L., De Greve, J., Schallier, D., De Couck, M., Gidron, Y., Maréchal, R.

Volltext

Magnetic braking at work in binaries von Van Rensbergen, W., De Greve, J. P.

Volltext

Geographical distribution of Slovenian BRCA1/2 families according to family origin: implications for genetic screening von Krajc, M, Zadnik, V, Novaković, S, Stegel, V, Teugels, E, Bešič, N, Hočevar, M, Vakselj, A, De Grève, J, Žgajnar, J

Volltext

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma von Sadones, J, Michotte, A, Veld, P, Chaskis, C, Sciot, R, Menten, J, Joossens, E.J.R, Strauven, T, D’Hondt, L.A, Sartenaer, D, Califice, S.F.E.H, Bierau, K, Svensson, C, De Grève, J, Neyns, B

Volltext

Accretion disks in Algols: Progenitors and evolution von Van Rensbergen, W., De Greve, J. P.

Volltext

Pemetrexed-induced Eyelid Edema: Incidence and Clinical Manifestations von SCHALLIER, D, DECOSTER, L, FONTAINE, C, DE GREVE, J

Volltext

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects von Goelen, G, Teugels, E, Bonduelle, M, Neyns, B, De Grève, J

Volltext

Spin-up and hot spots can drive mass out of a binary von Van Rensbergen, W., De Greve, J. P., De Loore, C., Mennekens, N.

Volltext

Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18 FDG-PET), after induction chemotherapy predicts a favourable outcome in patie... von Decoster, L, Schallier, D, Everaert, H, Nieboer, K, Meysman, M, Neyns, B, De Mey, J, De Grève, J

Volltext

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma von Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., Baurain, J.-F., D'Hondt, L., Strauven, T., Chaskis, C., In't Veld, P., Michotte, A., De Greve, J.

Volltext

Phase II study of sunitinib malate in patients with recurrent high-grade glioma von Neyns, B., Sadones, J., Chaskis, C., Dujardin, M., Everaert, H., Lv, S., Duerinck, J., Tynninen, O., Nupponen, N., Michotte, A., De Greve, J.

Volltext